Clinical Trial Update: Olanzapine in Patients With Borderline Personality Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating olanzapine for Borderline Personality Disorder has completed. No results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED